Mirati Therapeutics Inc

30. juuli 2026, 23:56 UTC

Old Dominion Freight Line shares lower in after-market hours after UBS raised its price target to $228 while maintaining a Neutral rating.

30. juuli 2026, 23:56 UTC

DICK'S Sporting Goods Inc. sees gains in after-market trading, supported by solid fundamentals and recognition as a value stock despite mixed performance momentum.

30. juuli 2026, 23:56 UTC

Viking Therapeutics Inc. shows a modest gain in after-market hours amid a wave of biopharmaceutical mergers, including Vertex's $10 billion acquisition of Crinetics.

30. juuli 2026, 23:56 UTC

Check Point Software Technologies reported earnings of $2.55 per share, surpassing expectations of $2.45. Shares are little changed in after-market trading.

30. juuli 2026, 23:52 UTC

Amazon.com Inc shares rose in after-hours trading following strong second-quarter results, with net sales of $200.6 billion surpassing analyst expectations.

30. juuli 2026, 23:51 UTC

Kimberly-Clark announced a $10 million commitment for recovery efforts in Wisconsin's Fox Valley, moving higher in after-market hours amid broader market gains.

30. juuli 2026, 23:51 UTC

Boston Scientific shares are higher in after-market trading following UBS's Buy rating and a price target adjustment to $67 amid Penumbra's results.

30. juuli 2026, 23:51 UTC

Castle Biosciences reported second-quarter revenues of $103.5 million, exceeding estimates. Shares are sharply higher in after-market trading following the earnings and guidance update.

30. juuli 2026, 23:51 UTC

Hercules Capital reported second-quarter earnings of $0.50 per share, exceeding estimates. Shares are higher in after-market trading following the strong results.

30. juuli 2026, 23:51 UTC

EMCOR Group Inc. reported record second-quarter results, with revenue of $5.15 billion and EPS of $9.06, raising full-year guidance. Shares are higher in after-market hours.

30. juuli 2026, 23:51 UTC

Lam Research Corp shares rose in after-market hours following strong second-quarter results, with adjusted EPS of $1.82 and optimistic third-quarter revenue guidance of $8.1 billion.

30. juuli 2026, 23:51 UTC

Dexcom reported second-quarter revenue of $1.308 billion and adjusted EPS of $0.70, raising its fiscal year 2026 revenue guidance, with shares trading higher in after-market hours.

30. juuli 2026, 23:51 UTC

Roblox Corp shares fell in after-hours trading following a narrower net loss of $183 million but disappointing revenue and guidance for third-quarter bookings.

30. juuli 2026, 23:51 UTC

Replimune Group shares are advancing in after-market trading following a favorable FDA advisory vote on its melanoma treatment RP1, despite earlier declines during the session.

30. juuli 2026, 23:51 UTC

Apple Inc reported fiscal Q3 revenue of $109.4 billion, but shares fell in after-hours trading due to weaker-than-expected guidance and missed services revenue.

30. juuli 2026, 23:46 UTC

TFS Financial Corp reported third-quarter EPS of $0.11, surpassing estimates. Shares are higher in after-market trading following strong earnings and revenue results.

30. juuli 2026, 23:46 UTC

Eastman Chemical Co reported second-quarter net earnings of $183 million, up from $140 million last year, with shares trading roughly flat in after-market hours.

30. juuli 2026, 23:46 UTC

UBS raised its price target on Xylem Inc. to $135, as shares traded higher in after-market hours following a dip earlier in the session.

30. juuli 2026, 23:46 UTC

Yum Brands reported a cyclospora outbreak linked to Taco Bell affecting sales. Shares are trading higher in after-market hours, continuing recent upward momentum.

30. juuli 2026, 23:46 UTC

Shares of Netflix are lower in after-market trading following Anne Sweeney's resignation from the board, confirmed not to be due to any disagreement.

30. juuli 2026, 23:41 UTC

CareDx Inc reported second-quarter revenue of $132 million, exceeding estimates. Following strong results and raised guidance, shares are higher in after-market trading.

30. juuli 2026, 23:41 UTC

Karyopharm Therapeutics shares fell sharply after its Phase 3 trial for selinexor failed to meet key endpoints, leading to a shift in focus away from endometrial cancer.

30. juuli 2026, 23:41 UTC

MicroStrategy reported a second-quarter loss of $8.62 billion, significantly missing expectations. Shares are trading higher in after-market hours amid broader market gains.

30. juuli 2026, 23:41 UTC

Illumina Inc shares declined in after-market trading despite strong second-quarter results and raised full-year EPS guidance, reflecting concerns over falling net income.

30. juuli 2026, 23:41 UTC

Stryker Corp shares fell in after-market trading despite reporting adjusted EPS of $3.69 and raising full-year guidance to $14.95 to $15.10.

30. juuli 2026, 23:41 UTC

Cerus Corporation shares declined in after-market hours following a revenue miss and lowered full-year guidance, despite second-quarter earnings matching estimates.

30. juuli 2026, 23:41 UTC

Cognizant Technology Solutions shares are lower in after-market trading despite stable revenue and increased profit guidance in its recent second-quarter update.

30. juuli 2026, 23:41 UTC

Micron Technology's after-market hours trading rises significantly, driven by a broader market rally and a $153 billion increase in market capitalization.

30. juuli 2026, 23:41 UTC

Bloom Energy Corp shares are higher in after-market hours, driven by strong performance in the Heavy Electrical Equipment sector and significant revenue growth.

30. juuli 2026, 23:41 UTC

PTC Inc. gained in after-market hours, driven by strong quarterly results and raised revenue guidance, reaching a high of 2.82% since Thursday's close.